Figueroa-Tarrillo JA, Cerna-Viacava R, Linares-Linares MA, Carreazo NY

Language: Spanish
References: 18
Page: 200-203
PDF size: 284.90 Kb.

ABSTRACT

An 11-year-old scholar arrives in the emergency room with right-knee monoarthritis due to local trauma, fever, sensory loss, and dyspnea. He is hospitalized and receives empiric antibiotic therapy. The blood culture set is positive for Streptococcus pyogenes and the antibiotic spectrum is changed. However, the patient’s general status deteriorates, and he is admitted to the intensive care unit. Even with the treatment received, he develops septic shock and multiorganic failure, requiring hemodynamic and ventilatory support. Thirty-eight hours after his admission, the patient dies.

REFERENCES

1. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med. 1996; 334(4): 240-245.

2. Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis. 2007; 45(4): 450-458.

3. Nogami Y, Tsuji K, Banno K, Umene K, Katakura S, Kisu I, Tominada E, Aoki D. Case of streptococcal toxic shock syndrome caused by rapidly progressive group A hemolytic streptococcal infection during postoperative chemotherapy for cervical cancer. J Obstet Gynaecol Res. 2014; 40(1): 250-254.

4. Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009; 9(5): 281-290.

5. Carapetis JR, Steer AC, Mulholland EK et al. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005; 5(11): 685-694.

6. Lamagni TL. The epidemiology of severe Streptococcus pyogenes disease in Europe. University of Helsinki. J Clin Microbiol. 2008; 46(7): 2359-2367.

7. O’Grady KA, Kelpie L, Andrews RA et al. The epidemiology of invasive group A streptococcal disease in Victoria, Australia. Med J Aust. 2007; 186: 565-569.

8. Steer AC, Jenney AWJ, Kado J et al. Prospective surveillance of invasive group A streptococcal disease, Fiji, 2005-2007. Emerg Infect Dis. 2009; 15: 216-222.

9. Hoge CW, Schwartz B, Talkington DF et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. JAMA. 1993; 269: 384-389.

10. Breiman R, Davis J, Facklam R, Gray B, Hoge C, Kaplan E et al. Defining the group A streptococcal toxic shock syndrome, rationale and consensus definition. JAMA. 1993; 269(3): 390-391.

11. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev. 1995; 8: 411-426.

12. Low DE. Toxic shock syndrome: major advances in pathogenesis, but not treatment. Crit Care Clin. 2013; 29(3): 651-675.

13. Brown EJ. The molecular basis of streptococcal toxic shock syndrome. N Engl J Med. 2004; 350: 2093-2094.

14. Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL et al. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin Infect Dis. 2005; 41(5): 599-608.

15. López AJM, Valerón LME, Consuegra LE, Urquía ML, Morón SCA, González JR. Síndrome de shock tóxico estreptocócico letal en pediatría: presentación de 3 casos. Med. Intensiva. 2007; 31(2): 100-103.

16. Rodríguez-Nuñez A, Dosil-Gallador S, Jordan I. Clinical characteristics of children with group A streptococcal toxic shock syndrome admitted to pediatric intensive care units. Eur J Pediatr. 2011; 170: 639-644.

17. Daskalaki MA, Boeckx W, DeMey A, Frank D. Toxic shock syndrome due to group A beta-hemolytic streptococcus presenting with purpura fulminans and limb ischemia in a pediatric patient treated with early microsurgical arteriolysis. J Pediatr Surg. 2013; 48: E1-E3.

18. Fox K, Born M, Cohen M. Fulminant infection and toxic shock syndrome caused by Streptococcus pyogenes. J Emerg Med. 2002; 22(4): 357-366.